AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...
Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, ...
“Emphysema is part of a group of lung conditions which comes under the umbrella term chronic obstructive pulmonary disease ...
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
Multiple chemicals in cigarette smoke and e-cigarettes alter the function of a key type of lung immune cell. Cigarette ...
Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.
The disease affects more than 30 million Americans and is the fourth leading cause of death worldwide. People with COPD also experience ... help eliminate access to treatment barriers.” ...
The Clear Oral Syringes Segment Held the Largest Share in 2024, Accounting for 62.9% of Total Revenues Oral Syringes Market ...